Tumor CD155 expression is associated with resistance to anti-PD1 immunotherapy in metastatic melanoma
Lepletier, A., Madore, J., O’Donnell, J. S., Johnston, R. L., Li, X. Y., McDonald, E., … & Mallardo, D. (2020). Tumor CD155 expression is associated with resistance to anti-PD1 immunotherapy in metastatic melanoma. Clinical Cancer Research.